Pharmaceutical Pellets Market Report 2026

Pharmaceutical Pellets Market Overview

• Pharmaceutical Pellets market size has reached to $2.01 billion in 2025 • Expected to grow to $3.48 billion in 2030 at a compound annual growth rate (CAGR) of 11.7% • Growth Driver: Increasing Adoption Of Personalized Medicine Driving The Pharmaceutical Pellets Market Growth Due To Tailored And Precision-Based Therapies • Market Trend: Product Innovations Transforming The Pharmaceutical Pellets Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmaceutical Pellets Market?

Pharmaceutical pellets refer to a type of multi-particulate dosage form created by combining medications with finely ground excipients to create small, free-flowing, spherical, or semi-spherical particles. It is used to produce medication dose forms with prolonged release. The main technologies involved in pharmaceutical pellets are extrusion, fluid bed granulation, dry powder layering, solution and suspension layering, spray congealing, and spray drying. Extrusion refers to a manufacturing method that involves forcing material through a die with the desired cross-section to make items with a set cross-sectional profile. The mechanism of action includes diffusion, erosion, and osmosis by direct, melt, wet, and dry techniques pellets are prepared and used by various end-users such as pharmaceutical and nutraceutical industries.

What Is The Pharmaceutical Pellets Market Growth Forecast?

The pharmaceutical pellets market size is expected to see rapid growth in the next few years. It will grow to $3.48 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to growth in precision drug delivery solutions, increasing adoption of pellets in combination therapies, rising nutraceutical and functional ingredient demand, innovation in solvent-free and melt-based techniques, expansion of contract manufacturing organizations. Major trends in the forecast period include rising adoption of multi-particulate drug delivery systems, growing demand for controlled and sustained release formulations, increasing use of pellets in capsule and sachet dosage forms, expansion of pelletization in nutraceutical applications, technological advancements in coating and layering techniques.

Global Pharmaceutical Pellets Market Segmentation

1) By Technology: Extrusion, Fluid Bed Granulation, Dry Powder Layering, Solution And Suspension Layering, Spray Congealing, Spray Drying 2) By Mechanism Of Action: Diffusion, Erosion, Osmosis 3) By Technique: Direct, Melt, Wet, Dry 4) By End-User: Pharmaceutical, Nutraceutical Subsegments: 1) By Extrusion: Melt Extrusion, Solvent-Based Extrusion 2) By Fluid Bed Granulation: Top-Spray Granulation, Bottom-Spray Granulation 3) By Dry Powder Layering: Powder Layering On Inert Cores, Coating Techniques 4) By Solution And Suspension Layering: Solution Layering, Suspension Layering 5) By Spray Congealing: Hot Melt Spraying, Cooling Methods 6) By Spray Drying: Single-Stage Spray Drying, Multi-Stage Spray Drying

What Is The Driver Of The Pharmaceutical Pellets Market?

The increasing adoption of personalized medicine is expected to propel the growth of the pharmaceutical pellets market going forward. Personalized medicine refers to tailoring medical treatment to the individual characteristics of each patient, often using molecular diagnostics and biomarkers. The rise in personalized medicine is being driven by advances in genomics and diagnostic technologies that enable treatments to be matched precisely to a patient’s genetic profile. Pharmaceutical pellets, which allow for flexible, small-batch, and precisely controlled drug delivery, are particularly suited for personalized dosing and combination therapies. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit advocacy group, in 2023, 26 new personalized treatments were approved by the U.S. Food and Drug Administration, including 20 new molecular entities and six gene- or cell-based therapies, compared to six rare disease therapies in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the pharmaceutical pellets industry.

Key Players In The Global Pharmaceutical Pellets Market

Major companies operating in the pharmaceutical pellets market are Abbott Laboratories, Takeda, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Colorcon Inc., Nordic Sugar AB, Pfizer, Merck & Co., Manus Aktteva Biopharma LLP, Thexa Pharma (P) Limited, Avanscure Lifesciences Private Limited, MB Sugars & Pharmaceuticals Limited, CIL Laboratories Pvt Ltd, Sainor Pharma Pvt Ltd, Umang Pharmatech Pvt Ltd, Nami Lifesciences Pvt Ltd, Lograns Pharma Private Limited, Rainbow Health Care Products, Chemit Laboratories, Concord Drugs Limited, Nanjing Joyfulchem Co. Ltd., Praful International Corporation, Pellets Pharma Limited, Vision Pharmacoat Pvt Ltd, Spansules Pharma, Ravoos Laboratories Ltd

Global Pharmaceutical Pellets Market Trends and Insights

Major companies operating in the pharmaceutical pellets market are focusing on developing advanced solutions to improve particle engineering, ensure high containment, and maintain precision in drug formulation processes. Particle engineering platforms refer to technological systems that enable controlled manufacturing of pharmaceutical pellets with desired size, shape, and potency, ensuring safety, efficacy, and regulatory compliance. For instance, in May 2024, Schedio SA, a US-based engineering company, launched the High Potent Pilot Particle Engineering Platform. This advanced platform supports up to 465 configurations and integrates with spray dryers and jet mills, aimed at enhancing particle engineering for high-potency compounds in the pharmaceutical industry. It features high containment and user-friendly controls, designed to ensure safety, precision, and regulatory compliance in pharmaceutical manufacturing processes.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Pellets Market?

In March 2023, Colorcon Inc., a US-based pharmaceutical film coating company, acquired Airnov Healthcare Packaging for an undisclosed amount. The acquisition of Airnov Healthcare Packaging by Colorcon enhances the latter's portfolio by adding critical capabilities in controlled atmosphere packaging, including moisture and oxygen protection solutions, thereby expanding Colorcon's platform of stability and moisture management offerings for the pharmaceutical industry. Airnov Healthcare Packaging is a France-based controlled atmosphere packaging company that employs active materials, innovative plastic processing, and functional design to offer products tailored for protecting pharmaceuticals from the detrimental effects of moisture and oxygen.

Regional Insights

North America was the largest region in the pharmaceutical pellets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Pellets Market?

The pharmaceutical pellets market consists of revenues earned by entities by providing services such as formulation development, manufacturing and production, customization, and tailoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical pellets market also includes sales of granulated itraconazole pellets and Rabeprazole pellets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Pellets Market Report 2026?

The pharmaceutical pellets market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical pellets industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.